Freeze-drying process for preparation of bortezomib for injection

A technology for bortezomib and injection, which is applied in the field of freeze-drying technology for preparing bortezomib for injection, which can solve the problems of poor resolubility and other problems, and achieve the effects of qualified clarity, good resolubility and high product safety

Inactive Publication Date: 2017-01-11
BEIJING JIMEITANG MEDICINE RES CO LTD
View PDF0 Cites 14 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The purpose of the present invention is to provide a freeze-drying process for preparing bortezomib for injection, which can effectively overcome the problems of spray bottle and poor resolubility of this product

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Freeze-drying process for preparation of bortezomib for injection

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] Embodiment 1 (sample 1)

[0037] The subpackaged bortezomib intermediate medicinal solution is freeze-dried by the following freeze-drying process:

[0038] (1) Pre-freezing stage: evenly put the bottles containing the liquid medicine into the freeze dryer;

[0039] (1.1) Lower the temperature of the plate layer from room temperature to -50°C at a rate of 1.5°C / min, and keep it warm for 2 hours;

[0040] (1.2) Raise the temperature of the plate layer to -12°C at a rate of 1°C / min, and keep it warm for 3 hours;

[0041] (1.3) Cool down the plate layer to -50°C at a rate of 1°C / min and keep it warm for 2 hours;

[0042] (1.4) Raise the temperature of the plate layer to -12°C at a rate of 1°C / min, and keep it warm for 3 hours;

[0043] (1.5) Cool down the plate layer to -50°C at a rate of 1°C / min and keep it warm for 3 hours;

[0044] (2) Sublimation drying:

[0045] (2.1) After pre-freezing, start vacuuming, control the vacuum degree to 20Pa, and raise the temperatur...

Embodiment 2

[0050] Embodiment 2 (sample 2)

[0051] The subpackaged bortezomib intermediate medicinal solution is freeze-dried by the following freeze-drying process:

[0052] (1) Pre-freezing stage: evenly put the bottles containing the liquid medicine into the freeze dryer;

[0053] (1.1) Lower the temperature of the plate layer from room temperature to -50°C at a rate of 1.5°C / min, and keep it warm for 2 hours;

[0054] (1.2) Heat the plate layer to -10°C at a rate of 1°C / min and keep it warm for 2 hours;

[0055] (1.3) Cool down the plate layer to -50°C at a rate of 1°C / min and keep it warm for 2 hours;

[0056] (1.4) Raise the temperature of the plate layer to -10°C at a rate of 1°C / min and keep it warm for 2 hours;

[0057] (1.5) Cool down the plate layer to -50°C at a rate of 1°C / min and keep it warm for 3 hours;

[0058] (2) Sublimation drying:

[0059] (2.1) After pre-freezing, start vacuuming, control the vacuum degree to 20Pa, and raise the temperature of the plate layer t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a freeze-drying process for preparation of bortezomib for injection, and according to the process, after subpackage of a bortezomib liquor, freeze-drying is performed, main features of a pre freezing stage comprise two times of annealing, in a sublimation drying stage, drying is kept for 30-40h at -30 DEG C. The bortezomib for injection prepared by the process is not spurted from a bottle, has full and complete appearance, good solubility, qualified clear degree and high safety, and is suitable for industrial production.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a freeze-drying process for preparing bortezomib for injection. Background technique [0002] Bortezomib (PS-341) is a dipeptidyl boronic acid compound with high efficiency and specific proteasome inhibition. Approved by the FDA for listing, the trade name is The dosage form is freeze-dried powder injection (injection), which is used for the treatment of multiple myeloma and mantle cell lymphoma. Xi'an Janssen Pharmaceutical Co., Ltd. obtained the import registration approval of bortezomib for injection in China in March 2005. [0003] Bortezomib is poorly soluble in water. The existing preparation methods of bortezomib for injection mostly use tert-butanol to solubilize, but after lyophilization, the preparation needs to be reconstituted with 0.9% sodium chloride injection, which has difficulties in reconstitution and poor clarity. Unqualified question. In addi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/05A61K31/69A61K9/19A61P35/00F26B5/06
Inventor 李建鲍立嵘
Owner BEIJING JIMEITANG MEDICINE RES CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap